Did any adverse reactions happen during this study?
Summary of adverse reactions during this study
Participants Participants Participants
with AML with DLBCL with MM Total
(out of 27 (out of 22 (out of 18 (out of 67
participants) participants) participants) participants)
How many
participants had 63.0% (17) 81.8% (18) 94.4% (17) 77.6% (52)
adverse reactions?
How many
participants had
22.2% (6) 13.6% (3) 27.8% (5) 20.9% (14)
serious adverse
reactions?
How many
participants left
11.1% (3) 27.3% (6) 38.9% (7) 23.9% (16)
this study due to
adverse reactions?
What serious adverse reactions happened during this study?
The most common serious adverse reaction that happened during this study was a
fever and a decrease in the number of neutrophils. Neutrophils are a type of white
blood cell that fight infection and disease.
There were 1.5% of participants who died due to serious adverse reactions during
this study. This was 1 out of 67 participants. This participant had AML and the
serious adverse reaction that led to death was a disease of the liver, gallbladder, or
bile ducts.
10 | Clinical Study Results